Bibliometric visualization of hepatocellular carcinoma and metabolic syndrome research: trends and emerging areas

被引:0
作者
Chen, Kang [1 ]
Feng, Qianye [2 ]
Liu, Haipeng [1 ]
机构
[1] Lanzhou Univ, Hosp 2, Dept Gen Surg, Lanzhou 730000, Gansu, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha 410011, Hunan, Peoples R China
关键词
Bibliometrics; Hepatocellular carcinoma; Metabolic syndrome; Visualization; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; UNITED-STATES; HEALTH; CANCER; ASSOCIATION; DYSFUNCTION; PREVALENCE; OBESITY; RISK;
D O I
10.1007/s12672-025-02518-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A growing body of research has highlighted the increasing relevance of hepatocellular carcinoma (HCC) and metabolic syndrome (MetS). However, a comprehensive bibliometric visualization analysis on this topic remains lacking. In this study, we retrieved 310 related articles from the Web of Science Core Collection, spanning from January 1, 2014, to December 31, 2023. Using VOS viewer and Cite Space software, we analyzed the relationships among authors, journals, institutions, countries, keywords, and citations. Between 2014 and 2023, there has been a steady increase in publications on HCC and MetS, with the United States and China being the leading contributors in terms of publication volume. The visualization analysis revealed that obesity, insulin resistance, MAFLD, and liver cirrhosis are emerging areas in the intersection of HCC and MetS. Additionally, the international community is increasingly adopting the disease diagnosis term MAFLD, which, compared to NAFLD, shows improved diagnostic performance for predicting both hepatic and extra-hepatic outcomes. Furthermore, hypertension and cardiovascular diseases are emerging as promising new research fields.
引用
收藏
页数:16
相关论文
共 45 条
[1]   Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17) [J].
Anjana, Ranjit Mohan ;
Unnikrishnan, Ranjit ;
Deepa, Mohan ;
Pradeepa, Rajendra ;
Tandon, Nikhil ;
Das, Ashok Kumar ;
Joshi, Shashank ;
Bajaj, Sarita ;
Jabbar, Puthiyaveettil Kottayam ;
Das, Hiranya Kumar ;
Kumar, Ajay ;
Dhandhania, Vinay Kumar ;
Bhansali, Anil ;
Rao, Paturi Vishnupriya ;
Desai, Ankush ;
Kalra, Sanjay ;
Gupta, Arvind ;
Lakshmy, Ramakrishnan ;
Madhu, Sri Venkata ;
Elangovan, Nirmal ;
Chowdhury, Subhankar ;
Venkatesan, Ulagamathesan ;
Subashini, Radhakrishnan ;
Kaur, Tanvir ;
Dhaliwal, Rupinder Singh ;
Mohan, V .
LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (07) :474-489
[2]   Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease [J].
Bo, Tao ;
Gao, Ling ;
Yao, Zhenyu ;
Shao, Shanshan ;
Wang, Xuemin ;
Proud, Christopher G. ;
Zhao, Jiajun .
CELL METABOLISM, 2024, 36 (05) :947-968
[3]   Metabolic Syndrome Pathophysiology and Predisposing Factors [J].
Bovolini, Antonio ;
Garcia, Juliana ;
Andrade, Maria Amparo ;
Duarte, Jose Alberto .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2021, 42 (03) :199-214
[4]   Selective versus total insulin resistance: A pathogenic paradox [J].
Brown, Michael S. ;
Goldstein, Joseph L. .
CELL METABOLISM, 2008, 7 (02) :95-96
[5]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[6]   Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD [J].
De, Arka ;
Bhagat, Naveen ;
Mehta, Manu ;
Taneja, Sunil ;
Duseja, Ajay .
JOURNAL OF HEPATOLOGY, 2024, 80 (02) :e61-e62
[7]   Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth [J].
Dong, XC ;
Park, SM ;
Lin, XY ;
Copps, K ;
Yi, XJ ;
White, MF .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :101-114
[8]   NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options [J].
Foerster, Friedrich ;
Gairing, Simon Johannes ;
Mueller, Lukas ;
Galle, Peter Robert .
JOURNAL OF HEPATOLOGY, 2022, 76 (02) :446-457
[9]   Metabolic syndrome and survival of patients with hepatocellular carcinoma: A meta-analysis [J].
Fu, Jia ;
Jiang, Jinqiong ;
Liu, Kanghan .
FRONTIERS IN ONCOLOGY, 2023, 13
[10]   99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical [J].
Hagstroem, Hannes ;
Vessby, Johan ;
Ekstedt, Mattias ;
Shang, Ying .
BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2024, 56 :E76-E77